Summit Therapeutics, Daiichi Sankyo and AstraZeneca Launch Clinical Collaboration to Evaluate Ivonescimab and Datroway in Solid Tumors Summit Therapeutics Inc. (Nasdaq: SMMT) has announced a clinical trial collaboration agreement with Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) to investigate…
Samsung Bioepis and Teva Expand Global Biosimilar Partnership to Advance Up to Six Candidates Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) have announced an expanded strategic collaboration to develop and commercialize up to six…
As artificial intelligence moves from pilot projects to everyday practice across the life sciences industry, the Medical Affairs Professional Society (MAPS) will bring together leaders from pharma, biotech and MedTech for the 2026 Medical Affairs Technology and Innovation Symposium on…
Qurient Study in Science Advances Shows Q901 Can Enhance TOP1-Targeting ADC Activity Qurient Co., Ltd. (KRX: 115180), a clinical-stage biotechnology company focused on developing innovative cancer therapies, has announced the publication of a peer-reviewed study in Science Advances demonstrating the…
SpecialtyCare’s IONM Training Program Earns CAAHEP Accreditation, Advancing Clinical Education and Patient Safety SpecialtyCare, a leading provider of outsourced clinical services in the United States, has announced that its Intraoperative Neuromonitoring (IONM) Training Program has received accreditation from the Commission…
Junevity and Amorepacific Partner to Develop Next-Generation Skin Rejuvenation Cosmetics Junevity, a biotechnology company focused on extending human lifespan and healthspan, has entered into a strategic collaboration with Amorepacific Corporation, a global beauty and wellness company, to explore new approaches…
TECPR2 Research Foundation and Forge Biologics Partner to Advance AAV Gene Therapy for Ultra-Rare Neurological Disease The TECPR2 Research Foundation, a nonprofit organization focused on advancing research and development of treatments for patients affected by TECPR2-related disease, has announced a…
Alcon Launches Systane PRO Preservative-Free in Canada With Up to 12 Hours of Dry Eye Relief Alcon, a global leader in eye care, has announced the Canadian launch of Systane® PRO Preservative-Free (PF), the company’s most advanced Systane formulation to…
Circle Pharma Strengthens Leadership Team to Advance Targeted Macrocycle Cancer Pipeline Circle Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation targeted macrocycle therapeutics for cancer, has announced two leadership appointments designed to support the company’s continued scientific development…
Susan G. Komen to Host Austin MORE THAN PINK Walk to Support Breast Cancer Research and Patient Care Susan G. Komen®, a leading breast cancer organization, is preparing to host the Austin MORE THAN PINK Walk on Sunday, October 25,…
Aptar Pharma and Macquarie University Launch Research Program to Advance Inhaled Biologic Delivery Aptar Pharma, a global provider of drug delivery, dosing and protection technologies and services, has announced a new research collaboration with Macquarie University in Australia to investigate…
Altasciences Supports 4B Healthcare’s RhineX Nasal Rinse Program Toward Phase I Clinical Testing Altasciences has announced that its recent drug product development and manufacturing work for 4B Healthcare Inc. has helped advance the company’s investigational RhineX nasal irrigation therapy into…